ArticleVaccine2023

Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France.

Cynthia Raissa Tamandjou Tchuem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.